Skip to Content

KU 7 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint KU 7 is Blue, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Kremers Urban Pharmaceuticals Inc..

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 7

Rabeprazole sodium delayed-release 20 mg KU 7
Rabeprazole sodium delayed-release 20 mg KU 7
Rabeprazole sodium delayed-release 20 mg KU 7
Rabeprazole sodium delayed-release 20 mg KU 7

Rabeprazole Sodium Delayed-Release

Imprint
KU 7
Strength
20 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Kremers Urban Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
62175-0302 Kremers Urban Pharmaceuticals Inc.
42291-0722 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "KU 7"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.